cabozantinib,atezolizumab
exelixis,roche
['urothelial carcinoma', 'atezolizumab', 'blcsm', 'cabozantinib', 'urothelial', 'cosmic-021']
great presenting cabozantinib in combination with atezolizumab in urothelial carcinoma (uc): results from cohorts 3, 4, 5 of the cosmic-021 study. #blcsm 
Medical Oncologist MD, PhD, BSc (Biol), GU & GYN cancers, Visiting Scholar UPenn, Athens Medical Center